Health Invest Partners Ab Alkermes Plc. Call Options Transaction History
Health Invest Partners Ab
- $221 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ALKS
# of Institutions
402Shares Held
178MCall Options Held
217KPut Options Held
426K-
Black Rock Inc. New York, NY29.1MShares$796 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$506 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$323 Million0.05% of portfolio
-
State Street Corp Boston, MA8.21MShares$225 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny5.81MShares$159 Million0.24% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.49B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...